Caffeine; the Forgotten Potential for Parkinson's Disease.

@article{Negida2017CaffeineTF,
  title={Caffeine; the Forgotten Potential for Parkinson's Disease.},
  author={Ahmed Negida and Mohamed Elfil and Attia and Eslam Farahat and M. Gabr and A. Essam and D. Attia and H. Ahmed},
  journal={CNS & neurological disorders drug targets},
  year={2017},
  volume={16 6},
  pages={
          652-657
        }
}
  • Ahmed Negida, Mohamed Elfil, +5 authors H. Ahmed
  • Published 2017
  • Psychology, Medicine
  • CNS & neurological disorders drug targets
  • BACKGROUND Parkinson's disease (PD) is the second most common neurological disorder characterized by loss of dopaminergic fibers in the basal ganglia and presence of Lewy bodies. METHOD AND RESULTS The literature suggests that caffeine plays multiple roles in PD. Epidemiological studies showed that caffeine intake was associated with less risk of developing PD, especially in genetically susceptible patients. On the level of Lewy bodies' formation, caffeine binds to α-synuclein protein… CONTINUE READING
    7 Citations
    Caffeine: An Overview of Its Beneficial Effects in Experimental Models and Clinical Trials of Parkinson’s Disease
    • 1
    • PDF
    Mitophagy could fight Parkinson’s disease through antioxidant action
    • 2
    • PDF
    ADORA2A rs5760423 and CYP1A2 rs762551 Polymorphisms as Risk Factors for Parkinson’s Disease
    Managing interactions between cognitive enhancers and other psychotropics